AMEDICUS THERAPEUTICS - Trademark Details
Status: 602 - Abandoned-Failure To Respond Or Late Response
Serial Number
78230737
Word Mark
AMEDICUS THERAPEUTICS
Status
602 - Abandoned-Failure To Respond Or Late Response
Status Date
2004-05-28
Filing Date
2003-03-27
Mark Drawing
1000 - Typeset: Word(s)/letter(s)/number(s)
Typeset
Attorney Name
Law Office Assigned Location Code
L50
Employee Name
PAPPAS, MATTHEW JAMES
Statements
Disclaimer with Predetermined Text
Therapeutics
Goods and Services
Pharmaceutical preparations for treatment of cardiovascular diseases
Goods and Services
Medical devices for treatment of cardiovascular diseases
Classification Information
International Class
5 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2003-04-03
Primary Code
005
International Class
10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials. - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
US Class Codes
026, 039, 044
Class Status Code
6 - Active
Class Status Date
2003-04-03
Primary Code
010
Correspondences
Name
Denise Hickey
Address
Please log in with your Justia account to see this address.
Trademark Events
| Event Date | Event Description |
| 2003-09-22 | ASSIGNED TO EXAMINER |
| 2003-10-06 | NON-FINAL ACTION E-MAILED |
| 2004-05-28 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
